Investigating the intra- and inter-rater reliability of a panel of subjective and objective burn scar measurement tools by Lee, Kwang Chear et al.
 
 
University of Birmingham
Investigating the intra- and inter-rater reliability of a
panel of subjective and objective burn scar
measurement tools
Lee, Kwang Chear; Bamford, Amy; Gardiner, A; Agovino, A; Ter Horst, Britt; Bishop, Jon;
Sitch, Alice; Grover, L; Logan, Ann; Moiemen, Naiem
DOI:
10.1016/j.burns.2019.02.002
License:
Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Lee, KC, Bamford, A, Gardiner, A, Agovino, A, Ter Horst, B, Bishop, J, Sitch, A, Grover, L, Logan, A & Moiemen,
N 2019, 'Investigating the intra- and inter-rater reliability of a panel of subjective and objective burn scar
measurement tools', Burns, vol. 45, no. 6, pp. 1311-1324. https://doi.org/10.1016/j.burns.2019.02.002
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Checked for eligibility: 03/10/2019
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
Investigating the intra- and inter-rater reliability
of a panel of subjective and objective burn scar
measurement tools$
K.C. Lee a, A. Bamford b, F. Gardiner b, A. Agovino a, B. ter Horst a,
J. Bishop c,1, A. Sitch d,1, L. Grover e, A. Logan f, N.S. Moiemen a,*
a Scar Free Foundation Centre for Burns Research, University Hospital Birmingham NHS Foundation Trust, Queen
Elizabeth Hospital Birmingham, Mindelsohn Way, Edgbaston, Birmingham, B15 2WB, UK
bUniversity Hospital Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Mindelsohn Way,
Edgbaston, Birmingham, B15 2WB, UK
c Birmingham Clinical Trials Unit (BCTU), Institute of Applied Health Research, University of Birmingham, Edgbaston,
Birmingham, B15 2TT, UK
d Test Evaluation Research Group, Institute of Applied Health Research, University of Birmingham, Edgbaston,
Birmingham, B15 2TT, UK
e School of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
f Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Edgbaston,
Birmingham, B15 2TT, UK
a b s t r a c t
Background: Research into the treatment of hypertrophic burn scar is hampered by the
variability and subjectivity of existing outcome measures. This study aims to measure the
inter- and intra-rater reliability of a panel of subjective and objective burn scar measurement
tools.
Methods: Three independent assessors evaluated 55 scar and normal skin sites using
subjective (modified Vancouver Scar Scale [mVSS] & Patient and Observer Scar Assessment
Scale [POSAS]) and objective tools. The intra-class correlation coefficient was utilised to
measure reliability (acceptable when >0.70). Patient satisfaction with the different tools and
scar parameter importance were assessed via questionnaires.
Results: The inter-rater reliabilities of the mVSS and POSAS were below the acceptable limit.
For erythema and pigmentation, all of the Scanoskin and DSM II measures (except the b*
value) had acceptable to excellent intra and inter-rater reliability. The Dermascan ultrasound
(dermal thickness, intensity) had excellent intra- and inter-rater reliability (>0.90). The
Cutometer R0 (firmness) had acceptable reliability but not R2 (gross elasticity). All objective
measurement tools had good overall satisfaction scores. Patients rated scar related pain and
itch as more important compared to appearance although this finding was not sustained
when corrected for multiple comparisons.
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Conclusion: The objective scar measures demonstrated acceptable to excellent intra- and
inter-rater reliability and performed better than the subjective scar scales.
© 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Research into burn scar treatment has increased in recent
years as the importance of post-recovery quality of life for burn
victims is being recognised. However, research into scar
treatments is hampered by the highly variable nature of burn
scars as they are influenced by both injury factors (e.g. cause,
depth of burn, infection, type and timing of surgical treatment
and time to healing [1]), surgical factors (e.g. number of
procedures, type of skin grafts [2]) and patient factors (e.g.
gender, ethnicity, age, anatomical site, comorbidities [2,3]).
Additional variability is introduced by the subjective
methods of evaluating scars which is prevalent in clinical
practice and research. Subjective scores such as the Vancouver
Scar Scale (VSS) and Patient and Observer Scar Assessment
Scale (POSAS) are commonly used [4] as they are low-cost,
quick and easy methods as well as validated and widely
published. The reproducibility of these subjective tools
however are highly reliant on the users; if utilised by trained
clinicians who have similar, agreed opinions on scars, the
reliability can be very good [5]. However this is rarely the case
outside of research where different clinicians’ judgement of
scars can be vastly different depending on their previous
experience with scars and patients’ perception of their own
scars can be similarly influenced by a myriad of factors such as
the trauma of the injuring event and the treatment process,
previous experiences, psychological state and visibility of the
scar [6]. Disagreement between scar ratings between clinicians
and patients is common [7] and differences can indicate the
presence of psychological distress [6].
The use of objective measurement methods can aid in
reducing this variability. Objective measurements are meth-
ods of quantifying a property of the scar that is minimally
influenced by the user, patient and the innate random and
systematic errors of the instrument itself, i.e. its reliability
[8]. Scar assessment consists of the measurement of multiple
components including colour (erythema and pigmentation),
pliability, thickness, and irregularity. A small number of
devices have been adapted from the cosmetics industry for
burn scar measurements as there is an increasing awareness
of the importance of reproducible and objective scar
measurements for both clinical practice and research.
However there is currently no consensus on the most
suitable tools for measurement of the different aspects of
scars due to the scarcity of scientific studies in these
instruments. This study is one of the first steps in establish-
ing a panel of objective scar measurement devices. In order
to inform the choice of the devices as well as to understand
the limitations of the different measurement methods.
Furthermore, the study aims to measure the reliability of
both subjective measurement tools as well as a panel of
objective measurement devices. It is hoped that the results in
this study will inform future scar research and improve the
accuracy, objectiveness and reproducibility of measured scar
outcomes in these studies.
2. Methods
The study was conducted in the Wellcome Trust Clinical
Research Facility at the Queen Elizabeth Hospital (QEHB),
Birmingham, United Kingdom. This study was approved by the
South Birmingham National Research Ethics Service (NRES)
Committee West Midlands (REC reference 15/WM/0378) as well
as the Research and Development Governance of the Univer-
sity Hospitals of Birmingham.
2.1. Study population
Fifty-five adult patients who have been treated at QEHB were
invited to participate in this study, and participation was
voluntary. Subjects were included in the study if they met the
following inclusion criteria: age 18 years and above, hypertro-
phic but non-keloid burn scar, scar aged more than 3 months
(calculated from time of 95% healing,) or have had a skin-
grafted area, or a burn that has had delayed healing (>2 weeks),
scar size of at least 10cm2. We excluded patients if they had
other pathological skin conditions, chronic steroid use and
scar areas on the genitalia or face. This was done to minimise
the interference of pathological skin on device readings for
example excessive skin flaking in psoriasis may clog the
suction based Cutometer, and abnormally rigid skin (e.g.
scleroderma) or loose skin (e.g. Ehler Danlos) will give
abnormal control skin values which will make analysis of
scar to normal skin ratios and correlations difficult due to
outlier values.
Potential subjects were identified from outpatient scar
management therapy lists by clinicians and therapists or from
multi-disciplinary team meetings and ward rounds. They were
then contacted by a member of the research team; either by
telephone or during routine clinical appointments and a brief
explanation of the trial was given. If they agreed to participate
in the study, a Patient Information Leaflet (PIL) was then sent to
the participant.
2.2. Measurement procedures
The study was a prospective, non-blinded single-arm obser-
vational study using three independent assessors. A graphical
overview of the study design and pathway for the scar
assessment study day is shown in Fig. 1.
All study participants had a single scar site which was
deemed the worse by both patient and clinician chosen. The
clinicians were largely guided by the patient in the selection of
the scar site. The clinicians’ role was to ensure that the
selected scar site met the protocol of the study (e.g. not on the
face or genitalia areas) and could be feasibly measured by the
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devices. If there were disagreements, a consensus was sought
between the patient and three clinicians. Within this scar site,
a 33cm area was then selected and marked. One 1cm circle
site was then selected and marked (with a stencil and marker
pen) for evaluation within this area on each participant. One
site of normal skin (1cm circle area) that is corresponding to
the same anatomical site (contralateral site, or adjacent
anatomic site) was also chosen for measurements. Similarly,
the site was selected and marked for evaluation within this
area on each subject. The 1cm size of the marking was chosen
as a balance between being bigger than the aperture sizes of
the devices (0.6–0.8cm) and small enough to minimise
variability due to relocation.
If the patients were wearing pressure garments or gels/
moisturisers, they were asked to remove them at least 20min
before their appointment. Measurements were conducted in
the same temperature controlled room (22+/–1C) with the
patient lying in the same position for each consecutive
measurement. The temperature and humidity of the room
was measured and monitored.
This scar site (as well as a normal skin site which was
contralateral or adjacent to the measured scar site) was
measured by 3 different assessors 3 times over a period of one
day with each of the devices in the panel of objective scar
measurement tools, a total of 9 measurements per device per
site. As the scars were measured in the same day, subjective
scar scales (mVSS and POSAS) were only completed once by
each of the three assessors and patient. For the objective
measurement devices, the normal skin sites (contralateral or
adjacent) of the patients served as the control groups.
2.3. Raters
The same three raters (a clinician, research nurse and burns
occupational therapist) were used in the entirety of the study.
The burns research fellow, nurse and therapist have
formal training and experience in the methodology of scar
assessments. The burns research fellow prior to conducting
the clinical trial, which is part of his PhD thesis, had in-
depth training in all subjective and objective scar assess-
ments. The research nurse is a senior burn nurse who was
involved in scar assessment objective and subjective for
years prior to the trial. The occupational therapist had 10
years’ experience in scar assessment and management of
post burn hypertrophic scarring including the objective
methods used in the trial.
In addition to this, all three raters were provided with
comprehensive training in the use of the objective scar
measurement devices under the supervision of the company
representatives of the respective devices and prior to the study
commencing, training sessions which involved the raters
using the devices on actual patients with burn scars were run
to allow the raters to familiarise themselves further with the
devices and also the running of the study.
2.4. Measurement tools
In a previously published study, a review of the current
literature on methods of objective scar measurements was
performed [9], and three parameters of scar assessment that
are the most commonly measured as well as the tools required
to measure them have been identified: pliability, scar
thickness and colour. These can be divided into subjective
and objective measurement tools.
2.4.1. Subjective measurement tools
All subjective measurement scales were completed with pen
and paper when face to face with the patient.
2.4.1.1. Modified Vancouver Scar Scale (mVSS). A modified
version of the VSS that was adapted from the modified version
used by Nedelec et al. [10,11] is used in this study (Table 8). This
scale uses a numerical assessment of four skin characteristics
including: Height (range, 0–4), Pliability (range, 0–4), Vascularity
(range, 0–3), and Pigmentation (range, 0–3). The larger the
number the worse the scar. The assessors choose a numerical
value for each of these characteristics based on a comparison
with normal skin.
2.4.1.2. Patient and Observer Scar Assessment Scale (POSAS).
The Patient and Observer Scar Assessment Scale (POSAS,
version 2.0) is a subjective scar scale that consists of two parts:
a Patient Scale and an Observer Scale [5]. Both scales contain
six items that are scored numerically on a ten-step scale (i.e. 1–
Fig. 1 – Graphical overview of study design.
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10). A score of “1” being “no, not at all” and a score of “10” being
“yes, very much”. Together they make up the ‘Total Score’ of
the Patient and Observer Scale.
2.4.2. Objective measurement tools
2.4.2.1. DSM II Colormeter. The DSM II Colormeter (Cortex
Technology ApS, Denmark) is a small handheld device which
combines two methods of quantifying colour: narrow-band
spectrophotometry (melanin, erythema) and tristimulus re-
flectance colorimetry in a single measurement [12]. The
Colormeter consists of a probe which is made of a transparent
dome which houses 2 white LED lights and a colour sensor has
a skin measuring area of 4mm in diameter. Measurements
were done by placing the probe over the selected areas on the
scar. The probe is to be held perpendicular to the scar using
minimal pressure to avoid blanching of the scar.
2.4.2.2. Scanoskin camera. The Scanoskin camera system
(Leniomed Ltd, United Kingdom) is a new device which is a type
of spectrophotometer which is a device that can measure a
light beam’s intensity as a function of its colour (wavelength)
[13]. The system consists of a standard DSLR camera, a
polarising light filter, ring flash and Scanoskin software. The
polarising light filter and ring flash produces a standard
controlled lighting which illuminates the skin. Some of this
light is reflected and scattered from the surface of the skin.
This reflected light is captured with the DSLR camera and the
raw image is then processed by the Scanoskin software which
then splits it into 2 images, one for melanin (pigment found in
skin) and the other for haemoglobin (pigment found in red
blood cells) (Fig. 2). The image is first inverted (thus darker
pixel intensity will have higher values). The Region Of Interest
(ROI) is then traced using the Image-J software and then the
Histogram function is used to give the mean pixel intensity.
2.4.2.3. Dermascan 20MHz high frequency ultrasound. The
Dermascan C USB (Cortex Technology ApS, Denmark) is a high-
frequency (20MHz) ultrasound scanner that enables the
imaging of soft tissue at high resolution with a computer,
and comes with software that allows automated skin
thickness measurement [14].
In the study, a medium focus transducer was used with a
12mm wide viewing field and penetration depth of 15mm. Before
measurement, a thin layer of conducting ultrasound gel is applied
tothe transducer andthe transducer istobe heldperpendicularto
the scar sites to record a single echographic image for each site.
Mode 4 and a gain profile of 13 were set for all scans.
All measurements were performed with an ultrasound
frequency set at 1580m/s. Thickness measurements are then
generated by a single researcher with the provided dedicated
software (Advance Control 6 Analysis SW package, Cortex).
The B-mode is utilised to analyse the Images [15]. This mode
provides a two-dimensional ultrasound image display con-
sisting of pixels with varying intensities to represent the
amplitude of the returned echo signal. The thickness mea-
sured is defined as the distance between the top layer of the
dermis underneath the echogenic stratum corneum and the
inner layer of the dermis (in millimetres). Normal dermis is
highly echogenic due to the high amount of connective tissue
and collagen (Fig. 3). Scar tissue appears hypoechoic compared
to normal skin, and this may be due to the increased water
content of scar tissue due to aberrant proteoglycan
metabolism.
2.4.2.4. Cutometer elasticity probe. The Cutometer (MPA 580,
Courage and Khazaka GmbH, Germany) is an electronic
instrument that assesses skin elasticity [16]. The probe of
the device is placed over the area of measurement, which then
generates a negative pressure that draws the skin into a hollow
aperture in the centre of the probe and then uses a laser to
estimate the amount of skin displacement.
The probe with a 6-mm diameter hollow aperture was
chosen for this study as previous studies have determined it to
be the most efficient size to measure the visco-elasticity
properties of the dermis. For this study, mode 1 was chosen.
This delivers three cycles of negative air pressure (500mbar)
for 2s, followed by 2s of no pressure. Results are expressed as
the means of the three measurement cycles. The most
commonly reported R-parameters, R0 and R2 were used in
this study. R0 describes the maximum deformation (exten-
sion) of the skin. R2 is the ratio of the final retraction and the
maximum deformation.
2.5. Statistical analyses
All statistical analyses of the data were performed using IBM
SPSS Statistics, version 23 (IBM Corporation, New York, USA)
and Stata version 15. P values of <0.05 are considered to signify
statistical significance.
Fig. 2 – Scanoskin images: (a) original image, (b) haemoglobin image, (c) pigmentation image.
Dermascan 20MHz high frequency ultrasound
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2.5.1. Sample size
The primary outcome was the intra and inter-reliability of a
panel of objective scar measurement devices. To estimate the
ICC with a 95% CI with an interval no greater than 0.2,
according to the methods in Shoukri et al. [17], the required
sample size was a minimum of 54 subjects. The 95% CI width of
0.2 was chosen due to a mixture of desired precision and
pragmatism and allowed for an attainable sample size for the
study.
Testing was conducted on 55 patients for all measures/
scales except where indicated.
2.5.2. Reliability
Reliability of a measurement refers to the consistency of the
data when the same trait is measured by the same assessor
(intra-rater reliability) or by different assessors (inter-rater
reliability) with the same measurement device.
The intra- and inter-rater reliability of the objective (DSM II
Colormeter, Cutometer, Dermascan, Scanoskin) and subjective
measurement tools (total mVSS and POSAS Scores; sum of
pliability, height, and vascularity subscales) were examined by
calculating the the Intraclass Correlation Coefficients (ICC) with
95% Confidence Intervals (CI). The ICC’s (2,3) were computed as
per Shrout and Fleiss [18] based on the two-way random effect
analysis of variance model with the absolute agreement type
being selected for ICC calculations. ICC agreement and
consistency were calculated by fitting a random effects model
accounting for the clustering of readers within patients and
reads within readers with models fitted using restricted
maximum likelihood (REML) which allowed estimates of the
variability at the levels of between patients, between readers
and within readers to be calculated from these ICCs [19].
The two-way random effect method was selected as the
raters in this study are consistent (i.e. the same three raters
throughout the study) and are a sample of raters (rather than a
fixed population). In addition to the ICC, the Standard Error of
Mean (SEM) and the Coefficient of variation ([CV=Standard
error/mean]100) are also reported.
The three measurements performed by each assessor for
each device were used to calculate the intra-rater ICC for each
assessor and then the average of the three intra-rater ICC
values was calculated. For the inter-rater ICC, the mean of all
three assessments for each device was calculated for each
assessor and then subsequently used to calculate the ICC.
The ICC gives the proportion of variability at the between
participant level (values close to 1 show less variability in the
process of obtaining the measure). The ICC can be reported as a
“single measure ICC” or an “average measure ICC”. The single
measure ICC is based on a randomly taken single measure-
ment and is equivalent to the reliability of a measurement
carried out by a single observer. The average measure ICC is
based on the average measurements of three observers and
thus is equivalent to the reliability of a measurement carried
out by three observers. An ICC value of 0.70 was selected as the
minimal threshold requirement for measurements to be
deemed reliable.
As the POSAS subscales are rated from 1 to 10 (and
ordered,), they can be treated as a continuous variable and
hence the ICC is used to calculate the reliability. For the mVSS
subscales, as the scoring is categorical and mostly ordinal in
some subscales, the Fleiss kappa [20] (instead of the Cohen’s
kappa which is only suitable for 2 raters) and Krippendorf’s
alpha were reported. The reliability of the total score of the
mVSS however was calculated using the ICC as it is the sum of
the scores and can be viewed as a continuous variable. Similar
to the ICC, a negative or low kappa/Krippendorf alpha score (0
or 0 to 0.20) indicates “no agreement” and a minimum value of
0.70 was chosen as the threshold to be deemed acceptable
although it is noted in the literature that lower values (0.40–
0.60) have been accepted as adequate [21,22].
2.5.3. Patient rated scar parameter importance
Patients were also be asked to rank the different scar
parameters (surface area, thickness, colour [erythema and
pigmentation], pliability, and pain/itch) in terms of impor-
tance to them, with 1 being the most important, to 6 being the
least important to them. The Friedman and Wilcoxon signed-
rank test was performed to examine the differences in ranking
of the different scar parameters and the differences in
parameters are reported with p-values.
Fig. 3 – High frequency ultrasound image of scar and normal skin.
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3. Results
3.1. Study population
3.1.1. Demographics
In total, 55 participants were successfully recruited for this
study between January to October 2016. The study was
conducted by organising 27 outpatients clinics with 1–3
patients in each with the average time taken for each patients
being about 3h. There were 37 males and 18 females, and the
mean age was 46 years (range: 18–77 years). The majority of
participants were Caucasian (82%). The demographics of the
participants and the clinical characteristics of the scar sites
chosen for evaluation are reported in Table 1.
Most of the participants were male (n=37, 67.2%) and the
mean total body surface area (TBSA) burned was 16.5%. The
scars were measured an average of 14.6 months after time of
95% healing (which was calculated as 7days after the last
grafting procedure unless there is evidence in the patient
records of delayed healing). The most commonly measured
scar area was on the upper limb (41.8%) and the most
common cause of scars in our cohort were flame burns
(58.2%).
3.2. Subjective Scar Scales
The ICC and kappa values for the mVSS and POSAS scores are
presented in Table 2. The total score of the mVSS (Pliability
+Height+Vascularity+Pigmentation) and the POSAS (Vascu-
larity+Pigmentation+Thickness+Relief+Pliability+Surface
area) are the sums of the individual subscales. As both the
mVSS and POSAS requires the comparison of the evaluated
site (scar site) with the normal skin, the ICC of these two scores
for normal skin cannot be evaluated as there should be total
agreement. Additionally, the intra-rater kappa and ICC values
also could not be performed as each assessor only completed
the subjective scores once. This was because all assessments
for the patients had to be completed in the same day and the
subjective scores would be heavily influenced by recall bias.
Analyses of both the total scores as well as the individual
subscales were performed.
For the mVSS, the kappa values for all the subscales of
pliability, height, vascularity and pigmentation all fell well
below the study set threshold of 0.70, with the lowest being
for pigmentation (0.02) which indicates no agreement. The
single and average ICC scores for the mVSS Total score
performed better than the subscales, with a value of 0.415
and 0.68 but still remained below the acceptable threshold.
Even with the Alpha-Krippendorff analysis which treats the
mVSS as an ordinal score (and therefore better reliability for
scores with adjacent values,), all of the values are still below
0.70.
For the POSAS score, the ICC (Single) values for the Total
score and the individual subscales all fall below the 0.70
threshold with the lowest score being for Surface area (0.003).
The POSAS however performs better with higher reliability
scores compared with the mVSS in the corresponding
subscales: mVSS Pliability versus POSAS Pliability (0.149;
0.384), mVSS Height versus POSAS Thickness (0.031; 0.492);
mVSS Vascularity versus POSAS Vascularity (0.241; 0.646) and
mVSS Pigmentation versus POSAS Pigmentation (0.02; 0.304).
The ICC scores of the Total scores for both mVSS and POSAS
were similar (0.415 versus 0.438). The removal of the subscale
with the lowest reliability (Surface area) improves the ICC
(Single) value of the POSAS Total score but not enough to reach
the acceptable threshold (ICC Single=0.528). The ICC (Average,
three assessors) for the POSAS individual subscales and Total
score showed improved reliability compared to the ICC (Single)
with the Vascularity, Thickness subscales and Total scores
showing ICC values above the set threshold for acceptability or
close to the threshold (Relief, Pliability, Overall subscales).
However, other subscales (Pigmentation and Surface area)
were still below the acceptable limit. Further analyses were
then performed to investigate if the ICC (Average) of two
assessors were equivalent or similar to three assessors,
however as Table 3 shows, the ICC (Average) of three assessors
for the subscales and Total score were better compared to two
assessors.
Table 1 – Clinical characteristics of patients recruited into
study.
Clinical characteristics n=55
Gender
Male:female 37:18
Age
MeanSD 4617.8 years
Range 18–77 years
TBSA of burn injury
MeanSD 16.518.2%
Range 0.50–60.00%
Age of scar (months after burn)
MeanSD 14.6
Range 2–43 months
Aetiology
Flame 32
Scald 16
Contact 5
Electrical 2
Location
Upper limb 23
Lower limb 12
Chest 2
Abdomen 13
Back 5
Previous treatment of scar site
Conservative (non-grafted) 9
Grafted 46
Fitzpatrick skin type
I 1
II 11
III 14
IV 18
V 11
VI 0
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3.3. Objective devices
3.3.1. DSM II Colormeter: Erythema and pigmentation
3.3.1.1. Erythema measurements. Erythema can be measured
with the DSM II a* and the narrow band Erythema parameters.
The inter- and intra-rater ICC values for the a* and narrow
band Erythema parameters can be seen in Table 4.
The a* value was found to have acceptable inter- (ICC
[Single, Average]=0.718, 0.884) and intra-rater (Average ICC
[Single, Average]=0.731, 0.87) ICC values for scar tissue. The
ICC single value for the a* measurement of normal skin
however was considerably lower compared to scar tissue
(ICC=0.595 versus 0.718) although the average ICC values were
comparable (ICC=0.815 versus 0.884). When this is analysed in
more detailed by looking at the intra-rater ICC values for the
individual assessors, it can be seen that this reduction in ICC is
likely to be due to the reduced reliability of the measurements
by Assessor 2 (a* ICC value [Single]=0.508 versus 0.915 for
Assessor 1 and 0.952 for Assessor 3). When the ICC measure-
ments were analysed in pairs rather than all three assessors,
the lowest ICC value was found between Assessors 2 and 3 (ICC
[Single]=0.399).
The a* ICC agreement for scar tissue was calculated to be
0.571 (95% CI 0.457, 0.685) and for normal skin the ICC was
lower at 0.474 (0.507, 0.739).
The narrow band Erythema value was also found to have
acceptable inter- (ICC [Single, Average]=0.777, 0.912) and intra-
rater ICC values (Average ICC [Single, Average]=0.74, 0.87) for
scar tissue. Similar to the a* value for normal skin, the ICC of
the Erythema measurement for normal skin (ICC [Single]
=0.647) was lower than that of scar tissue (ICC [Single]=0.777).
As with the a* value, when analysed in pairs, the lowest ICC
value was found between Assessor 2 and 3 (ICC [Single]=0.450).
For the erythema measure the ICC agreement for scar tissue
was 0.622 (95% CI=0.517–0.728) and for normal skin was again
lower at 0.510 (95% CI=0.386–0.634).
For both measures and skin types, the CV was greatest at
the between patient level; however, the within reader CV was
larger than the between reader CV.
Of the two erythema measures, both the a* and narrow
band Erythema measure have similar inter- and intra-rater
reliability values as well as %CV, thus both are recommended.
However for erythema measurements on normal skin, more
than 1 measurement should be taken to improve reliability.
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). Table 3 – The ICC (Average) of two assessors versus three
assessors.
POSAS subscales ICC (average)
Two assessors Three assessors
Vascularity 0.78 0.85
Pigmentation 0.41 0.57
Thickness 0.65 0.74
Relief 0.54 0.63
Pliability 0.55 0.65
Surface area 0.03 0.01
Overall 0.57 0.66
Total 0.61 0.70
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3.3.1.2. Pigmentation measurements. Pigmentation can be
measured with the DSM II L*, b* and the narrow band Melanin
parameters. The inter- and intra-rater ICC values for the L*, b*
and narrow band Melanin parameters can be seen in Table 5.
The L* value was found to have good inter- (ICC [Single,
Average]=0.942, 0.980) and intra-rater (Average ICC [Single,
Average]=0.90, 0.97) ICC values for scar tissue. The L*
parameter had an ICC agreement of 0.882 (95% CI: 0.839–
0.925). The inter-and intra-rater for the L* value for normal
skin, although lower, were also all above the set threshold of
0.70 (ICC Single or Average=0.806–0.960).
The narrow band Melanin value was also found to have good
inter- (ICC [Single, Average]=0.930, 0.975) and intra-rater (Average
ICC [Single, Average]=0.93, 0.97) ICC values for scar tissue. For the
melaninmeasuretheICCagreementwassimilarwith88.4%ofthe
variability at the between-participant level (ICC=0.884 (0.841,
0.928)).The inter-and intra-rater for the Melanin value for normal
skin were also similarly high with inter-rater values of 0.836 (ICC
Single) and 0.939 (ICC Average); and intra-rater values of 0.90 (ICC
Single) and 0.96 (ICC Average).
The b* value however performed the worst out of the three
objective pigmentation measures. For the measures of L* and
melanin the largest CV was between patients, however for the
measure of b* the largest CV was at the within reader level. The
b* value for scar tissue had a low inter-rater ICC (Single) value
of 0.525, but acceptable ICC (Average) value of 0.768 for scar
tissue, although this is with a high %CV of 32.58%. The b* intra-
rater ICC (Single) value for scar tissue was just below the
threshold (ICC Single=0.62) but the ICC (Average) was good
(ICC Average=0.80). Both the ICC (Single) and ICC (Average)
Table 4 – Inter-rater ICC values for the erythema measures of the DSM II Colormeter for scar tissue and normal skin.
Measure Scar tissue Normal skin
a* Erythema a* Erythema
Mean 16.12 15.02 13.28 10.30
IQR 14.03–18.02 12.84–17.44 10.79–15.10 7.26–13.20
%CV (patient) 19.0 21.6 24.30 32.0
Inter-rater ICC
Single ICC (95% CI) 0.718 (0.601–0.813) 0.777 (0.678–0.854) 0.595 (0.424–0.732) 0.647 (0.488–0.769)
Average ICC (95% CI) 0.884 (0.819–0.929) 0.912 (0.863–0.946) 0.815 (0.689–0.891) 0.846 (0.741–0.909)
%CV (SEM) 9.65 (0.83) 9.45(0.73) 13.77 (1.09) 14.5 (0.90)
Intra-rater ICC
Single ICC (95% CI) 0.731 (0.233–0.949) 0.737 (0.260–0.938) 0.792 (0.352–0.970) 0.792 (0.283–0.985)
Average ICC (95% CI) 0.87 (0.477–0.983) 0.87 (0.477–0.978) 0.90 (0.620–0.990) 0.89 (0.542–0.995)
%CV (SEM) 9.83 (0.87) 10.03 (0.84) 9.43 (0.76) 8.93 (0.58)
Agreement and consistency
ICC agreement (95% CI) 0.571 (0.457–0.685) 0.622 (0.517–0.728) 0.474 (0.343–0.604) 0.510 (0.386–0.634)
ICC consistency (95% CI) 0.649 (0.546–0.753) 0.677 (0.580–0.773) 0.623 (0.507–0.739) 0.627 (0.516–0.738)
Table 5 – Inter-rater and intra-rater ICC values of the pigmentation measures for the DSM II Colormeter for scar tissue and
normal skin.
Measure Scar tissue Normal skin
L* b* Melanin L* b* Melanin
Mean 27.07 6.61 46.36 37.67 9.97 35.80
IQR 22.36–32.41 3.95–8.69 39.63–49.97 37.75–43.34 7.59–12.66 30.96–38.15
%CV (patient) 26.0 42.1 20.6 18.1 24.1 20.0
Inter-rater ICC
Single ICC (95% CI) 0.942 (0.908–0.964) 0.525 (0.370–0.666) 0.930 (0.893–0.956) 0.806 (0.576–0.903) 0.351 (0.178–0.523) 0.836 (0.677–0.909)
Average ICC (95% CI) 0.980 (0.967–0.988) 0.768 (0.638–0.857) 0.975 (0.962–0.985) 0.926 (0.803–0.965) 0.618 (0.393–0.767) 0.939 (0.873–0.968)
%CV (SEM) 6.14 (0.88) 32.58 (1.09) 4.06 (1.13) 8.10 (1.63) 32.19(1.60) 6.69 (1.43)
Intra-rater ICC
Single ICC (95% CI) 0.90 (0.774–0.963) 0.64 (0.202–0.879) 0.93 (0.851–0.992) 0.90 (0.729–0.985) 0.62 (0.152–0.930) 0.90 (0.771–0.984)
Average ICC (95% CI) 0.97 (0.911–0.987) 0.82 (0.431–0.956) 0.97 (0.945–0.992) 0.96 (0.890–0.995) 0.80 (0.350–0.976) 0.96 (0.910–0.995)
%CV (SEM) 6.87 (1.01) 59.84 (1.09) 4.42 (1.05) 5.20 (1.03) 63.88 (1.18) 5.00 (3.12)
Agreement and consistency
ICC agreement (95% CI) 0.882 (0.839–0.925) 0.362 (0.237–0.487) 0.884 (0.841–0.928) 0.749 (0.662–0.837) 0.220 (0.096–0.345) 0.780 (0.702–0.858)
ICC consistency (95% CI) 0.903 (0.867–0.939) 0.437 (0.309–0.565) 0.924 (0.894–0.953) 0.886 (0.841–0.930) 0.313 (0.167–0.460) 0.889 (0.847–0.932)
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values of the b* measure were below the acceptable threshold
for normal skin. The b* intra-rater ICC (Single) value for normal
skin was just below the threshold (ICC Single=0.62) but the ICC
(Average) was good (ICC Average=0.80).
3.3.2. Scanoskin camera: Erythema and pigmentation
Due to technical difficulties and errors in the flash power
(resulting in photo underexposure), only 31 of the patients had
Scanoskin camera photos which were analysable (B25 to B55).
The inter- and intra-rater ICC values for the Scanoskin
parameters can be seen in Table 6.
The Scanoskin erythema measure had very high reliability
values for both inter- (ICC [Single, Average]=0.969, 0.989) and
intra-rater (ICC[Single, Average]=0.995, 0.998) ICC values for
scar tissue. The Scanoskin erythema measure for normal skin
also had slightly lower but similarly high inter- (ICC [Single,
Average]=0.926, 0.974) and intra-rater (ICC[Single, Average]
=0.985, 0.995) ICC values.
The same trend was seen with the Scanoskin pigmentation
measure, with analyses showing high inter- (ICC [Single,
Average]=0.972, 0.991) and intra-rater (ICC [Single, Average]
=0.989, 0.996) ICC values for scar tissue as well as normal skin,
inter-rater (ICC [Single, Average]=0.957, 0.985); intra-rater (ICC
[Single, Average]=0.994, 0.997).
The ICC agreement estimates for erythema and pigmenta-
tion were very high for the measurements of scar tissue, 0.966
(95% CI: 0.945–0.986) and 0.965 (95% CI: 0.946–0.985) respective-
ly. The ICC estimates when using the normal skin were similar.
The CV at the between patient level was largest for erythema
and pigmentation measures for both skin types and the within
reader CV was the smallest.
3.3.3. Dermascan ultrasound: dermal thickness and intensity
The inter- and intra-rater ICC values for the Dermascan
ultrasound dermal thickness and intensity measures are
shown in Table 7.
Dermascan measured dermal thickness had good inter-
(ICC [Single, Average]=0.957, 0.985) and intra-rater (ICC [Single,
Average]=0.951, 0.983) for scar tissue. The dermal thickness
measure for normal skin also had similarly high inter- (ICC
[Single, Average]=0.967, 0.989) and intra-rater (ICC [Single,
Average]=0.948, 0.982).The Dermascan measured dermal
intensity likewise had good inter- (ICC [Single, Average]
=0.918, 0.971) and intra-rater (ICC [Single, Average]=0.928,
0.937) for scar tissue. The dermal intensity measure for normal
skin also had similarly high inter- (ICC [Single, Average]=0.863,
0.950) and intra-rater (ICC [Single, Average]=0.931, 0.976).
Although both Dermascan measured dermal thickness and
intensity had similarly high ICC values, the %CV values for
Dermal intensity are higher compared to that for Dermal
thickness for both scar (16.4% versus 6.79%) and normal skin
(15.9% versus 5.13%).
The ICC agreement estimates were again high for the
thickness and intensity measures, 0.926 (95% CI: 0.898–0.955)
and 0.873 (95% CI: 0.826–0.921) respectively. Again the
estimates for normal skin were similar.
3.3.4. Cutometer: R0 and R2 measurements
Cutometer measurements were only available for 54 patients
as 1 patient did not have enough time during the session for the
Cutometer measurement. The inter- and intra-rater ICC values
for the Cutometer R0 and R2 measures are shown in Table 8.
The R0 measure had acceptable inter- (ICC [Single, Average]
=0.715, 0.883) and intra-rater ICC values (ICC [Single, Average]
=0.80, 0.92) for scar tissue. The R0 intra-rater ICC values for
normal skin was also acceptable (ICC [Single, Average]=0.85,
0.94) but only the ICC (Average) of the R0 inter-rater ICC was
above the set threshold (ICC Average=0.827) but not the ICC
Single (ICC Single=0.615). In contrast to the R0 value, the R2
measure for scar tissue only had acceptable Average Inter-
rater and intra-rater ICC (Average) values (ICC Average=0.758,
0.76) but its Single Inter-rater ICC (Single=0.510) and Intra-
Table 6 – Inter-rater and intra-rater ICC values of the erythema and pigmentation measures for the Scanoskin system for scar
tissue and normal skin.
Measure Scar tissue Normal skin
Erythema Pigmentation Erythema Pigmentation
Mean 78.29 81.12 31.65 98.42
IQR 53.78–108.76 54.90–98.79 13.68–47.82 81.00–116.53
%CV (patient) 48.2 38.5 69.8 24.4
Inter-rater ICC
Single ICC (95% CI) 0.969 (0.944–0.984) 0.972 (0.951–0.986) 0.926 (0.871–0.961) 0.957 (0.925–0.978)
Average ICC (95% CI) 0.989 (0.981–0.994) 0.991 (0.983–0.995) 0.974 (0.953–0.987) 0.985 (0.974–0.992)
%CV (SEM) 8.55 (3.32) 6.34 (2.59) 18.05 (2.78) 4.42 (2.43)
Intra-rater ICC
Single ICC (95% CI) 0.995 (0.985–0.998) 0.989 (0.955–0.998) 0.985 (0.962–0.994) 0.994 (0.940–0.997)
Average ICC (95% CI) 0.998 (0.995–0.999) 0.996 (0.995–0.999) 0.995 (0.987–0.998) 0.997 (0.979–0.999)
%CV (SEM) 3.44 (3.31) 3.25 (2.59) 10.4 (2.76) 2.34 (2.43)
Agreement and consistency
ICC agreement (95% CI) 0.966 (0.945–0.986) 0.965 (0.946–0.985) 0.917 (0.870–0.963) 0.949 (0.921–0.978)
ICC consistency (95% CI) 0.995 (0.993–0.998) 0.989 (0.983–0.995) 0.984 (0.975–0.993) 0.987 (0.979–0.994)
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rater (Single=0.52) values were all below the acceptable
threshold. Both the single inter- (ICC Single=0.510) and
intra-rater (ICC Single=0.52) ICC values for the R2 measure
for normal skin were below the threshold but the average
inter- (ICC Average=0.758) and intra-rater (ICC Average=0.76)
ICC values reached acceptable levels.
We further analysed our data by dividing the group into
scars with mVSS Pliability scores of <2 and above 2 (Table 9).
Whilst the inter-rater R0 ICC values for normal scars (ICC
[Single, Average]=0.718, 0.884) were better than the firmer
hypertrophic scars (ICC [Single, Average]=0.568, 0.798), the
R2 inter-rater ICC values for hypertrophic scars showed a
reverse trend and were higher than that for non-hypertro-
phic scars.
3.3.5. Patient satisfaction with devices questionnaire
All of the objective measurement devices had over 90% of
“Very good” and “Good” ratings in all three of the patient
satisfaction parameters of overall satisfaction, comfort and
time to measure. Interestingly, high patient satisfaction was
also found for the more invasive skin biopsy procedure though
slightly lower compared to the non-invasive tools (average %)
in terms of overall satisfaction (87.9% versus 96%), comfort
(78.8% versus 95.5%), and time to measure (90.6% versus
95.1%).
3.3.6. Patient rated scar parameter importance
Responses were available from 54 of the 55 patients for patient
rated scar parameter importance (Table 10).
Table 7 – Inter- and intra-rater reliability values for the Dermascan ultrasound thickness and intensity measurements for
scar tissue and normal skin.
Measure Scar tissue Normal skin
Dermal thickness Dermal intensity Dermal thickness Dermal intensity
Mean 2.65 10.59 1.47 28.60
IQR 1.97–3.25 5.72–14.42 1.10–1.64 18.57–38.73
%CV (patient) 40.1 64.4 33.5 46.5
Inter-rater ICC
Single ICC (95% CI) 0.957 (0.934–0.973) 0.918 (0.874–0.948) 0.967 (0.949–0.980) 0.863 (0.796–0.912)
Average ICC (95% CI) 0.985 (0.977–0.991) 0.971 (0.954–0.982) 0.989 (0.982–0.993) 0.950 (0.921–0.969)
%CV (SEM) 6.79 (0.10) 16.4 (0.90) 5.13 (0.04) 15.9 (2.42)
Intra-rater ICC
Single ICC (95% CI) 0.951 (0.871–0.987) 0.928 (0.881–0.976) 0.948 (0.881–0.976) 0.931 (0.855–0.966)
Average ICC (95% CI) 0.983 (0.953–0.996) 0.937 (0.947–0.991) 0.982 (0.954–0.993) 0.976 (0.947–0.989)
%CV (SEM) 7.33 (0.10) 13.68 (0.90) 5.35 (0.04) 12.62 (2.42)
Agreement and consistency
ICC agreement (95% CI) 0.926 (0.898, 0.955) 0.873 (0.826, 0.921) 0.947 (0.927, 0.968) 0.823 (0.758, 0.889)
ICC consistency (95% CI) 0.951 (0.931, 0.970) 0.923 (0.894, 0.953) 0.947 (0.927, 0.968) 0.924 (0.894, 0.954)
Table 8 – Inter- and intra-rater reliability values for the Cutometer R0 and R2 measures for scar tissue and normal skin.
Measure Scar tissue Normal skin
R0 R2 R0 R2
Mean 0.61 0.77 1.09 0.82
IQR 0.503–0.740 0.720–0.825 9.08-1.26 0.77–0.88
%CV (patient) 31.3 9.4 20.9 8.2
Inter-rater ICC
Single ICC (95% CI) 0.715 (0.522–0.834) 0.542 (0.385–0.683) 0.615 (0.373–0.772) 0.510 (0.348–0.660)
Average ICC (95% CI) 0.883 (0.766–0.938) 0.780 (0.653–0.866) 0.827 (0.641–0.910) 0.758 (0.616–0.853)
%CV (SEM) 17.15 (0.06) 7.84 (0.03) 14.74 (0.09) 5.90 (0.03)
Intra-rater ICC
Single ICC (95% CI) 0.80 (0.529–0.930) 0.58 (0.225–0.807) 0.85 (0.687–0.928) 0.52 (0.206–0.783)
Average ICC (95% CI) 0.92 (0.771–0.976) 0.79 (0.465–0.926) 0.94 (0.868–0.975) 0.76 (0.438–0.916)
%CV (SEM) 13.29 (0.04) 7.89 (0.03) 7.97 (0.05) 7.35 (0.03)
Agreement and consistency
ICC agreement (95% CI) 0.601 (0.485–0.718) 0.373 (0.246–0.501) 0.544 (0.408–0.679) 0.335 (0.210–0.459)
ICC consistency (95% CI) 0.736 (0.646, 0.826) 0.455 (0.325, 0.585) 0.803 (0.724, 0.882) 0.400 (0.271, 0.529)
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A statistically significant difference in patient perceived
scar parameter importance was found (Friedman test, chi
square=11.26, p=0.046). Pain and itch were shown to be the
most important scar parameter to patients and pigmentation
the least. To examine where differences in ranking actually
occurred, separate Wilcoxon signed rank tests on the different
combinations of the parameters were run. The Wilcoxon
signed-rank test showed that patients perceived scar thick-
ness to be significantly more important than pigmentation
(p=0.018) and surface area (p=0.049), whereas pain and itch
was perceived to be more important than pigmentation
(p=0.033).
Due to the multiple comparisons done, a Bonferroni
adjustment was performed, with the adjusted significant p-
value calculated to be 0.003 (i.e. 0.05/15 comparisons). After
adjustment, there were no statistically significant differences
between the parameters in terms of perceived importance.
4. Discussion
Accurate and reliable measurements of hypertrophic scarring
in burns are increasingly being recognised as important in both
clinical practice and research. This is especially true in the field
of wound healing where long term scarring is an important
outcome measure to determine the effectiveness of a surgical
procedure or treatment. In this study, both the intra- and inter-
rater reliability of the objective tools, i.e. the Cutometer, the
Dermascan ultrasound, the DSM II Colormeter, the Scanoskin
system were tested on both scar tissue as well as the matching
normal skin sites. Additionally, the inter-rater reliability of
commonly used subjective scales, the modified VSS and
POSAS were also tested. Comparisons of the objective scar
measurement tools with the mVSS, POSAS and also histologi-
cal parameters to test the validity of the objective measures
was performed but will be addressed in a separate study.
This study differs from previous similar studies in a number
of different ways. Firstly a power calculation was performed to
calculate the minimum number of participants required, and
as a result of this, a much larger number of patients have been
recruited (n=55) compared to other similar studies which
typically recruit around 30 subjects or less, for e.g. Nedelec
et al. [10,11], Gankande et al. [23] and Draaijers et al. [24].
Additionally, other reliability studies have performed their
measurements over an average 2 week period and not in a
single session as in this study [10,11,25]. This predisposes
these studies to errors due to relocating the exact site of
measurement despite rigorous protocols being utilised and
this is a common source of error that is acknowledged by
several studies. Thus the ICC values of the tools in these
studies are influenced substantially by the reliability of their
relocation protocol. However it has to be acknowledged that
although testing in a single day reduces error likely associated
with relocation, it does not mirror clinical practice and thus
actual reliability values could reasonably be expected to be
lower at other time intervals.
Our study has shown that the traditionally and widely used
subjective scar scales, the modified VSS and POSAS have poor
reliability when performed by less than three assessors for the
majority of the subscales with the exception of the POSAS
vascularity subscale which has an acceptable inter-rater
average ICC of 0.78 when performed by 2 assessors. Even with
three assessors, the mVSS total score as well as the POSAS
pigmentation, relief, pliability, change in surface area and
overall score still have lower than acceptable ICC values. The
reliability of the POSAS subscales is likely to be even lower as
these ICC values were calculated without taking into account
the additional categorical classifications each subscale pos-
sesses, for example the pigmentation subscale can be rated
into the categories of “Hypo”, “Hyper” and “Mix” in addition to
the 1–10 scale. The requirement of having three assessors for
acceptable reliability makes these subjective scores
Table 10 – Wilcoxon signed-rank test comparison of the scar parameters. The lower the rank, the more important the
parameter was to the patient. Parameters with statistically significant correlations are shaded in grey.
Parameters (p-values) Mean rank Std deviation Redness Pigmentation Surface area Thickness Pliability Pain/itch
Redness 3.70 1.74 n/a – – – – –
Pigmentation 4.01 1.70 0.16 n/a – – – –
Surface area 3.70 1.43 0.956 0.217 n/a – – –
Thickness 3.22 1.43 0.195 0.018 0.049 n/a – –
Pliability 3.46 1.73 0.574 0.218 0.429 0.258 n/a
Pain/itch 3.02 2.05 0.115 0.033 0.134 0.55 0.28 n/a
Table 9 – Differences in R0 and R2 inter-rater ICC values between normal scars (mVSS Pliability scores of 2 or less) and
hypertrophic scars (mVSS Pliability values of >2).
Measure Non-hypertrophic scars (mVSS Pliability score <2) Hypertrophic scars (mVSS Pliability >2)
R0 (n=21) R2 (n=21) R0 (n=33) R2 (n=33)
Single 0.718 0.294 0.568 0.567
ICC (95% CI) (0.431–0.876) (0.024–0.582) (0.341–0.747) (0.370–0.737)
Average 0.884 0.555 0.798 0.797
ICC (95% CI) (0.695–0.955) (0.070–0.807) (0.608–0.899) (0.638–0.894)
%CV (SEM) 14.47 (0.06) 6.52 (0.03) 18.87 (0.05) 8.68 (0.04)
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impractical for most clinical and research settings. One
explanation for the poor reliability of these subjective scores
is the lack of a standardised reference on which to score
against. The assessors are thus affected by both recall bias and
are also biased by their own personal experience of previously
seen scars when judging the assessed scar. Although an
increased number of scar assessments may improve the intra-
rater reliability of an assessor due to improved familiarity with
the scoring scale and the exposure to a wider range of scar
severity and types, there is no evidence that it makes the
assessment more accurate or improves inter-rater reliability
unless feedback is given to the assessor (e.g. comparing own
measures with a standard, to others or to an objective
measure).
The DSM II a* and narrow band Erythema had acceptable
inter- and intra-rater ICC values of above 0.70 for both single
and average measures for scar tissue. The inter-rater ICC
values for normal skin however were found to be lower
compared to that for scar tissue. The results point towards a
difference in the readings between raters, most likely due to
different pressures being applied to the measured site
resulting in varying levels of blanching, though a greater
difference would be expected to be seen in scars compared to
normal skin. Another explanation could be that the mea-
sured normal skin site had been irritated by multiple
measurements (and thus appearing more erythematous,)
by the other tools and insufficient time was allowed for the
skin to recover fully despite time being allocated in the
protocol for this. Our results are in contrast with other
studies which show that the erythema ICC values for normal
skin are usually similar or higher than that for scar sites
[10,12].
In terms of pigmentation measurement, the DSM II L*, and
narrow band Melanin parameters both show high inter- and
intra-rater ICC values of above 0.90 for both single and average
measures although the b* measure had poor reliability values
which is in contrast with the reliability of the b* value of similar
colour measurement systems such as the Labscan XE184 [25].
Our analyses have shown that this is likely to be due to the fact
that the b* parameter is affected by both pigmentation
(“yellowness”) as well as skin circulation (likely venous
circulation, “blueness”) as evidenced by the significant
correlations to both histologically measured melanin concen-
trations and CD31 measured vessel concentration thus leading
to greater variability (data not shown). Compared to the
pigmentation measures (other than the b* measure), the
objective measurements for erythema of the DSM II Color-
meter have lower ICC values. This again is likely due to the
erythema parameters being susceptible to the varying
amounts of pressure applied onto the area of measurement
which may cause different degrees of blanching in contrast to
pigmentation parameters which are not influenced by
pressure.
The Scanoskin camera system parameters for both erythe-
ma and pigmentation have been shown to have greater
reliability compared to the DSM II parameters, although more
observations are required to confirm this. An additional
advantage of the Scanoskin system is that it allows the
measurement of the parameters over a much greater area (up
to approximately 3500cm2, although light exposure at
peripheries will be lower than centre,) will be compared to
the DSM II which only has a measurement area of 4mm.
The Dermascan ultrasound system has been shown to have
high (ICC>0.90) inter- and intra-rater ICC (Single and Average)
values for both dermal thickness and intensity in scar tissue
and normal skin. In addition to this, the dermal thickness
parameter also had significant correlations with the subjective
height subscale of both the mVSS and POSAS-Observer as well
as histologically measure dermal thickness (p<0.01). This is in
agreement with most studies on the Dermascan system
[10,11,14]. A study by Agabalyan et al. [26] however reported
a weak correlation between the Dermascan measured ultra-
sound and histological measured dermal thickness (Spearman
rank correlation of 0.6242). There are some important
methodological differences between this study and ours. This
includes the small number of samples (n=10) compared to our
study (n=38), and the use of the H&E stain which will not allow
the authors to differentiate between scar tissue and uninjured
dermis. A flaw of the Dermascan system however is the
inability to adjust the image enhancement (mode) after the
image is taken compared to newer systems such as the DUB
Skinscanner system (Taberna Pro Medicum, Germany) [27],
which makes the detection of the lower dermal border difficult
particularly in thicker scars when using the same enhance-
ment mode as the thinner scars.
For pliability measures, the Cutometer R0 parameter had
acceptable inter and intra-rater ICC values for scar tissue but
the R2 parameter did not reach the required threshold.
Previous studies have shown both low and high reliability
values for the Cutometer dependent on the parameter being
evaluated [10,11,23,24]. In studies that have shown low inter-
rater reliability values, this was thought to be due to scars with
high rigidity [10,11] however in the study by Nedelec et al. [11]
this was found to be only true for the R0 value where the
normal skin R0 ICC value was higher than the scar tissue R0 ICC
value. The R2 value for normal skin (ICC=0.55) was however
lower than the R2 value for severe scar tissue (ICC=0.71) in that
study which agrees with our study findings. In our study, this
difference in reliability between softer and firmer scars had
been shown to be true for the R0 parameter but not the R2
parameter (Table 9).
Previous studies have shown both low and high reliability
values for the Cutometer are dependent on the parameter
being evaluated [10,11,23,24]. In studies that have shown low
inter-rater reliability values, this was thought to be due to scars
with high rigidity [10,11] however in the study by Nedelec et al.
[11] this was found to be only true for the R0 value where the
normal skin R0 ICC value was higher than the scar tissue R0 ICC
value. The R2 value for normal skin (ICC=0.55) was however
lower than the R2 value for severe scar tissue (ICC=0.71) in that
study which agrees with our study findings.
The study by Nedelec et al also attributed the reduced
reliability of the Cutometer to the sensitivity of the device to
slight differences in location [10]. However in our study, we
repeated the measurements in a single session (which should
significantly reduce relocation errors,) in contrast to the
Nedelec study where repeat measurements were done over
three sessions within a 2 week period, and despite this the
reliability of the Cutometer remained lower compared to the
other objective devices.
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Other studies give further insight into the reasons that may
contribute to the lower reliability of the Cutometer. Bonaparte
et al showed that removing the Cutometer probe in between
measurements resulted in a higher reliability compared to
leaving the probe in place [28]. This effect was thought to be
due to mechanical interference by the probe which prevents
skin recoil if the probe was not removed in between readings.
In a separate study by Bonaparte et al., they found that
moderate to heavy additional forces (50–500 grams) signifi-
cantly altered measurements [29]. Muller et al. also showed
similar findings that showed different contact forces between
the probe and skin surface can cause differences in the initial
deformation of the skin which can then lead to differences in
measurements [30].
Patients’ views and preferences are an important compo-
nent of developing a new investigation as poor patient
acceptance will inevitably lead to poor uptake or compliance.
Our study has shown that all the objective measurement
devices rated highly with the patients including time to
measure and comfort. Anecdotally, many of the patients also
found it fascinating to be able to have an alternate way to
visualise and monitor their scars on the measurement devices
e.g. the cross section ultrasound views and the result curves on
the Cutometer program. Thus time and cost permitting,
incorporating objective devices (e.g. at a few time intervals
in the scar treatment process,) this may further enhance
patient engagement in research or therapy.
When looking at the importance placed by patients on the
different parameters, although not statistically significant
after adjustment, the results may imply that physical comfort
(absence of pain and itch) and functionality were more
important factors to patients compared to appearance (surface
area and colour). However this may be due to the majority of
the scar being assessed being >12months old which means
that the scars are more likely to be mature scars with reduced
erythema. Additionally, the original findings may be upheld
with larger patient numbers thus further investigation is
warranted.
This study has shown that the subjective scales mVSS and
POSAS have much poorer reliability compared to the objective
devices. However subjective scales still have an important role
in clinical practice and certain advantages over objective
measurement devices. Subjective scales are advantageous
over objective devices in terms of cost and availability. Most, if
not all, of the subjective scales are free to use and are easily
obtainable from the internet whereas the objective devices
used in the study range from £5000 to £18000. This is especially
important in smaller units and in developing countries where
no additional funding for these devices would be available.
Subjective scales such as POSAS also allows the patient to rate
their own scars and therefore involve the patient in their own
care. There are also many limitations in objective devices that
are easier to overcome with subjective measures such as
measurement in difficult areas such as tight spaces which do
not fit the measurement probe or highly mobile areas such as
joints and large scars as most of the objective devices can only
measure small areas. The limited time available to spend on
patients in clinics also means that subjective measures are
more easily completed. Although subjective assessment is
extremely important as they may include patients’ perception,
the poor reliability of subjective assessments however mean
that they cannot be used solely as an assessment for of scars
e.g. in studies looking at the effectiveness of scar treatments.
They must be combined with, ideally, a panel of objective scar
measures.
There are a number of limitations to this study. Due to
the study design, patients only participated in a single
session for all measurements, and thus we were not able to
calculate the intra-rater reliability for the subjective scar
scales (mVSS and POSAS) or any longitudinal data for the
scars. A likely contributor to the high reliability of both the
Scanoskin and Dermascan measurements is the use of a
single researcher to perform all the processing and
measurements of the obtained images. This was unfortu-
nately not avoidable due to the time constraints and other
work commitments of the raters. For the Scanoskin camera
and the majority of the Dermascan images, the use of a
single researcher for all measurements is unlikely to have
introduced significant bias as the areas that had to be
delineated manually for measurement were very clear.
However in certain Dermascan images, especially the
thicker scars, the inner layer of the dermis can sometimes
be hard to visualise and thus some subjectivity is intro-
duced. Although all the clinicians were trained and
competent in the use of the devices before the start of
the study, at the final analysis it was found that some
clinicians had consistently lower reliability in certain
devices. This shows there is a need to check the intra-rater
reliability during either clinical practice or studies to ensure
that problems that lead to lower reliability can be identified
and ameliorated.
A high reliability of a measurement does not equate to a
high validity and this will be further investigated in a separate
related study where the measurements are validated against
the mVSS as well as histological markers which are the best
available “gold standard” currently. Histological markers
however themselves are subject to variability and artefacts
due to processing and interpretation and sampling bias.
In summary, we found that the reliability of the
subjective scores mVSS and POSAS both fell below the
acceptable threshold. For the objective tools, the following
had good to excellent intra and inter-rater reliability scores:
(1)The DSM II L* and narrow band Melanin measures for
pigmentation and the a* and narrow band Erythema values
for erythema, (2) The Dermascan thickness and intensity
measurements, the (3) Cutometer R0 and (4) The Scanoskin
Erythema and pigmentation measures. Therefore these
devices are recommended to be used in both clinical
practice and research in the measurements of burn scars
in combination with patient reported outcome measures
such as the Brisbane Burn Scar Impact Profile (BBSIP) [31] to
provide a well-rounded evaluation of burn scar and its
impact on the patients’ quality of life. At present, the high
cost of the objective devices, inexperience of clinicians with
their use and limited clinical time are major obstacles to
their wider adoption and means that the objective devices
are largely limited to commercial and research use but it is
hoped that this study will promote their use and also spur
more research into improving the objective measurement
tools and further innovations in objective measures.
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